A symphony of destruction: Dynamic differential fibrinogenolytic toxicity by rattlesnake (Crotalus and Sistrurus) venoms.


Journal

Comparative biochemistry and physiology. Toxicology & pharmacology : CBP
ISSN: 1532-0456
Titre abrégé: Comp Biochem Physiol C Toxicol Pharmacol
Pays: United States
ID NLM: 100959500

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 16 01 2021
revised: 02 03 2021
accepted: 15 03 2021
pubmed: 27 3 2021
medline: 1 9 2021
entrez: 26 3 2021
Statut: ppublish

Résumé

What factors influence the evolution of a heavily selected functional trait in a diverse clade? This study adopts rattlesnakes as a model group to investigate the evolutionary history of venom coagulotoxicity in the wider context of phylogenetics, natural history, and biology. Venom-induced clotting of human plasma and fibrinogen was determined and mapped onto the rattlesnake phylogenetic tree to reconstruct the evolution of coagulotoxicity across the group. Our results indicate that venom phenotype is often independent of phylogenetic relationships in rattlesnakes, suggesting the importance of diet and/or other environmental variables in driving venom evolution. Moreover, the striking inter- and intraspecific variability in venom activity on human blood highlights the considerable variability faced by physicians treating envenomation. This study is the most comprehensive effort to date to describe and characterize the evolutionary and biological aspects of coagulotoxins in rattlesnake venom. Further research at finer taxonomic levels is recommended to elucidate patterns of variation within species and lineages.

Identifiants

pubmed: 33766656
pii: S1532-0456(21)00061-2
doi: 10.1016/j.cbpc.2021.109034
pmc: PMC8162888
mid: NIHMS1698402
pii:
doi:

Substances chimiques

Crotalid Venoms 0
Fibrinogen 9001-32-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109034

Subventions

Organisme : NIH HHS
ID : P40 OD010960
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Références

Toxins (Basel). 2018 Mar 23;10(4):
pubmed: 29570631
Toxicol In Vitro. 2019 Mar;55:62-74
pubmed: 30471431
Genetics. 2017 Jul;206(3):1569-1580
pubmed: 28476866
J Med Toxicol. 2017 Dec;13(4):309-320
pubmed: 28975491
Proc Biol Sci. 2019 Mar 13;286(1898):20182735
pubmed: 30862287
J Proteomics. 2014 Jan 16;96:103-16
pubmed: 24211403
Toxicon. 1979;17(3):221-8
pubmed: 473237
Curr Biol. 2018 Apr 2;28(7):1016-1026.e4
pubmed: 29576471
J Proteome Res. 2006 Sep;5(9):2098-112
pubmed: 16944921
Zootaxa. 2020 Jan 31;4729(4):zootaxa.4729.4.1
pubmed: 32229836
Toxicon. 2005 Jun 15;45(8):997-1011
pubmed: 15922771
Annu Rev Genomics Hum Genet. 2009;10:483-511
pubmed: 19640225
Mol Phylogenet Evol. 2008 Nov;49(2):445-59
pubmed: 18804544
Genome Res. 2005 Mar;15(3):403-20
pubmed: 15741511
Toxins (Basel). 2016 Oct 22;8(10):
pubmed: 27782073
Mol Phylogenet Evol. 2016 Dec;105:50-62
pubmed: 27480810
Mol Phylogenet Evol. 2001 Nov;21(2):176-89
pubmed: 11697914
Toxicon. 2011 Apr;57(5):657-71
pubmed: 21255598
Mol Phylogenet Evol. 2015 Feb;83:213-23
pubmed: 25534232
Comp Biochem Physiol C Toxicol Pharmacol. 2018 Feb;205:62-69
pubmed: 29074260
Toxins (Basel). 2016 Oct 26;8(11):
pubmed: 27792190
Toxicon. 2017 Nov;138:119-129
pubmed: 28827138
Toxicon. 1972 Oct;10(6):557-62
pubmed: 4665359
Comp Biochem Physiol C Toxicol Pharmacol. 2017 Jul;197:53-60
pubmed: 28457945
Toxicon. 1999 Feb;37(2):249-52; author reply 253-60
pubmed: 10078860
Toxicol Lett. 2019 Nov;316:35-48
pubmed: 31509773
Toxins (Basel). 2019 Jul 19;11(7):
pubmed: 31331004
PLoS Negl Trop Dis. 2017 Jun 21;11(6):e0005662
pubmed: 28636631
Toxicon. 1973 Apr;11(3):301-3
pubmed: 4352855
Nature. 1996 Feb 8;379(6565):537-40
pubmed: 8596631
Mol Ecol. 2006 Oct;15(11):3353-74
pubmed: 16968275
Proc Biol Sci. 2009 Jul 7;276(1666):2443-9
pubmed: 19364745
Toxicon. 2010 Jul;55(8):1463-74
pubmed: 20227433
Toxins (Basel). 2019 Feb 06;11(2):
pubmed: 30736322
Toxicon X. 2019 Feb 05;2:100007
pubmed: 32550564
Curr Biol. 2016 Sep 26;26(18):2434-2445
pubmed: 27641771
PLoS One. 2013 Jun 24;8(6):e67220
pubmed: 23826238
Toxicon. 2010 Sep 15;56(4):544-53
pubmed: 20677373
J Proteome Res. 2010 Jan;9(1):528-44
pubmed: 19863078
J Proteomics. 2015 Jan 1;112:210-23
pubmed: 25252117
J Proteomics. 2011 Sep 6;74(10):2169-79
pubmed: 21722760
J Proteomics. 2012 May 17;75(9):2576-87
pubmed: 22446891
Toxicon. 2013 Sep;71:84-95
pubmed: 23732126
Toxicon. 2015 May;98:34-48
pubmed: 25727380
Genome Res. 2019 Apr;29(4):590-601
pubmed: 30898880
Rev Biol Trop. 2002 Mar;50(1):337-46
pubmed: 12298262
Ecol Evol. 2017 Apr 23;7(11):3951-3966
pubmed: 28616190
J Proteome Res. 2012 Feb 3;11(2):1382-90
pubmed: 22181673
Toxicon. 1983;21(1):119-30
pubmed: 6342208
Mol Ecol. 2020 Aug;29(15):2871-2888
pubmed: 32593182
Proc Biol Sci. 2016 Apr 27;283(1829):
pubmed: 27122552
Biol Lett. 2019 Feb 28;15(2):20180876
pubmed: 30958133
Proc Natl Acad Sci U S A. 2021 Jan 26;118(4):
pubmed: 33468678
Trends Ecol Evol. 2013 Apr;28(4):219-29
pubmed: 23219381
J Proteomics. 2014 Mar 17;99:68-83
pubmed: 24463169
Toxicon. 2009 May;53(6):672-9
pubmed: 19673082
Toxicol Lett. 2020 Jul 1;327:2-8
pubmed: 32199952
Toxicon. 1986;24(10):995-1000
pubmed: 3824406
Mol Phylogenet Evol. 2000 May;15(2):269-82
pubmed: 10837156
Toxicon. 2019 Dec;170:29-40
pubmed: 31513813
Toxicon. 1978;16(1):81-4
pubmed: 622731
Mol Cell Proteomics. 2008 Feb;7(2):215-46
pubmed: 17855442
J Proteome Res. 2017 Sep 1;16(9):3370-3390
pubmed: 28731347
J Proteomics. 2015 May 21;121:28-43
pubmed: 25819372
Toxicon. 1991;29(11):1279-303
pubmed: 1814005
Zootaxa. 2019 Oct 07;4683(1):zootaxa.4683.1.7
pubmed: 31715939
Toxins (Basel). 2020 Jan 23;12(2):
pubmed: 31979380
J Evol Biol. 2018 Oct;31(10):1513-1528
pubmed: 29959877
Comp Biochem Physiol C Toxicol Pharmacol. 2019 Nov;225:108567
pubmed: 31306806
J Proteomics. 2017 Jul 5;164:19-32
pubmed: 28554670
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10911-10920
pubmed: 32366667
Mol Phylogenet Evol. 2016 Apr;97:145-154
pubmed: 26802208
Proc Natl Acad Sci U S A. 1971 Jul;68(7):1560-3
pubmed: 5283946
Front Immunol. 2021 Mar 11;12:612846
pubmed: 33815366
J Mol Evol. 2008 Feb;66(2):151-66
pubmed: 18253686
Toxins (Basel). 2016 Jun 16;8(6):
pubmed: 27322321
Mol Biol Evol. 2017 Apr 1;35(4):887-898
pubmed: 29329419
Lancet. 2020 Jan 25;395(10220):e14
pubmed: 31982076
Toxicol In Vitro. 2019 Aug;58:195-206
pubmed: 30930232
Toxicon. 1985;23(5):825-44
pubmed: 3937297
Toxicon. 1989;27(4):411-8
pubmed: 2499081

Auteurs

Lorenzo Seneci (L)

Venom Evolution Lab, School of Biological Sciences, University of Queensland, St Lucia, QLD 4072, Australia; Institute of Biology Leiden (IBL), Leiden University, 2333 BE Leiden, the Netherlands.

Christina N Zdenek (CN)

Venom Evolution Lab, School of Biological Sciences, University of Queensland, St Lucia, QLD 4072, Australia.

Lachlan A Bourke (LA)

Venom Evolution Lab, School of Biological Sciences, University of Queensland, St Lucia, QLD 4072, Australia.

Chip Cochran (C)

Department of Earth and Biological Sciences, Loma Linda University, Loma Linda, CA 92350, USA.

Elda E Sánchez (EE)

National Natural Toxins Research Center (NNTRC), Department of Chemistry, Texas A&M University-Kingsville, MSC 224, 975 West Avenue B, Kingsville, TX 78363, USA.

Edgar Neri-Castro (E)

Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnologa, Universidad Nacional Autónoma de México, Av. Universidad 2001, Cuernavaca, Morelos 62210, Mexico.

Melisa Bénard-Valle (M)

Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnologa, Universidad Nacional Autónoma de México, Av. Universidad 2001, Cuernavaca, Morelos 62210, Mexico.

Alejandro Alagón (A)

Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnologa, Universidad Nacional Autónoma de México, Av. Universidad 2001, Cuernavaca, Morelos 62210, Mexico.

Nathaniel Frank (N)

MToxins, 717 Oregon Street, Oshkosh, WI 54902, USA.

Bryan G Fry (BG)

Venom Evolution Lab, School of Biological Sciences, University of Queensland, St Lucia, QLD 4072, Australia. Electronic address: bgfry@uq.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH